BioNexus Gene Lab Corp.

NASDAQ (USD): BioNexus Gene Lab Corp. (BGLC)

Last Price

0.461

Today's Change

+0.062 (15.53%)

Day's Change

0.372 - 0.525

Trading Volume

7,215,447

Overview

Market Cap

8 Million

Shares Outstanding

17 Million

Avg Volume

3,774,130

Avg Price (50 Days)

0.31

Avg Price (200 Days)

0.46

PE Ratio

-7.68

EPS

-0.06

Earnings Announcement

18-Nov-2024

Previous Close

0.40

Open

0.37

Day's Range

0.372 - 0.525

Year Range

0.211 - 3.39

Trading Volume

7,215,447

Price Change Highlight

1 Day Change

15.46%

5 Day Change

66.32%

1 Month Change

43.52%

3 Month Change

9.25%

6 Month Change

-0.69%

Ytd Change

15.46%

1 Year Change

-10.47%

3 Year Change

-96.54%

5 Year Change

-90.64%

10 Year Change

-90.64%

Max Change

-90.64%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment